as compared, below 1% of placebo patients withdrew because of dizziness and somnolence. Other good reasons for discontinuation with the trials, developing with bigger frequency while in the LYRICA team than within the placebo group, had been asthenia, confusion, and peripheral edema. Each individual of those situations brought about withdrawal in a